cisapride has been researched along with Cardiac Arrest, Sudden in 5 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
Excerpt | Relevance | Reference |
---|---|---|
"Adverse cardiac events, typically long QT syndrome, have been reported in patients treated with the gastrointestinal prokinetic agent cisapride." | 8.81 | Spontaneous adverse event reports of serious ventricular arrhythmias, QT prolongation, syncope, and sudden death in patients treated with cisapride. ( Barbey, JT; Lazzara, R; Zipes, DP, 2002) |
"We aimed to examine the association between cisapride and ventricular arrhythmia, and examine the relationship to dose and CYP3A4 inhibitors." | 7.74 | Cisapride and ventricular arrhythmia. ( Bilker, WB; Hennessy, S; Kimmel, SE; Leonard, CE; Newcomb, C, 2008) |
"Adverse cardiac events, typically long QT syndrome, have been reported in patients treated with the gastrointestinal prokinetic agent cisapride." | 4.81 | Spontaneous adverse event reports of serious ventricular arrhythmias, QT prolongation, syncope, and sudden death in patients treated with cisapride. ( Barbey, JT; Lazzara, R; Zipes, DP, 2002) |
"We aimed to examine the association between cisapride and ventricular arrhythmia, and examine the relationship to dose and CYP3A4 inhibitors." | 3.74 | Cisapride and ventricular arrhythmia. ( Bilker, WB; Hennessy, S; Kimmel, SE; Leonard, CE; Newcomb, C, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Healy, D | 1 |
Howe, G | 1 |
Mangin, D | 1 |
Le Noury, J | 1 |
Hennessy, S | 2 |
Leonard, CE | 2 |
Palumbo, CM | 1 |
Bilker, WB | 2 |
Newcomb, C | 2 |
Kimmel, SE | 2 |
Erickson, CC | 1 |
Jones, CS | 1 |
Barbey, JT | 1 |
Lazzara, R | 1 |
Zipes, DP | 1 |
1 review available for cisapride and Cardiac Arrest, Sudden
Article | Year |
---|---|
Spontaneous adverse event reports of serious ventricular arrhythmias, QT prolongation, syncope, and sudden death in patients treated with cisapride.
Topics: Arrhythmias, Cardiac; Cisapride; Death, Sudden, Cardiac; Gastrointestinal Agents; Humans; Long QT Sy | 2002 |
4 other studies available for cisapride and Cardiac Arrest, Sudden
Article | Year |
---|---|
Sudden cardiac death & the Reverse Dodo Verdict.
Topics: Antipsychotic Agents; Cisapride; Death, Sudden, Cardiac; Drug-Related Side Effects and Adverse React | 2014 |
Diagnostic codes for sudden cardiac death and ventricular arrhythmia functioned poorly to identify outpatient events in EPIC's General Practice Research Database.
Topics: Arrhythmias, Cardiac; Cisapride; Cohort Studies; Databases, Factual; Death, Sudden, Cardiac; Domperi | 2008 |
Cisapride and ventricular arrhythmia.
Topics: Adult; Aged; Arrhythmias, Cardiac; Case-Control Studies; Cisapride; Cytochrome P-450 CYP3A; Death, S | 2008 |
Pediatric sudden cardiac death: what the pediatrician needs to know.
Topics: Child; Cisapride; Contraindications; Death, Sudden, Cardiac; Gastrointestinal Agents; Humans; Risk F | 2000 |